Attributable mortality of nosocomial candidemia, revisited.
about
Bench-to-bedside review: therapeutic management of invasive candidiasis in the intensive care unitGenetic and phenotypic intra-species variation in Candida albicansInvasive candidiasis as a cause of sepsis in the critically ill patientCentral venous catheter (CVC) removal for adult patients with candidaemiaPatient isolation measures for infants with candida colonization or infection for preventing or reducing transmission of candida in neonatal unitsPatient isolation measures for infants with candida colonization or infection for preventing or reducing transmission of candida in neonatal unitsEndogenous thrombospondin-1 regulates leukocyte recruitment and activation and accelerates death from systemic candidiasisEffectiveness of anidulafungin in eradicating Candida species in invasive candidiasis.Phase 2, randomized, dose-ranging study evaluating the safety and efficacy of anidulafungin in invasive candidiasis and candidemiaIdentification and characterization of a previously undescribed family of sequence-specific DNA-binding domainsCentral venous catheter (CVC) removal for patients of all ages with candidaemiaThe Role of Autophagy-Related Proteins in Candida albicans InfectionsEmerging drugs and vaccines for candidemiaAll you need is light: antimicrobial photoinactivation as an evolving and emerging discovery strategy against infectious diseaseCandida colonization index and subsequent infection in critically ill surgical patients: 20 years laterAssociation of genotypes with infection types and antifungal susceptibilities in Candida albicans as revealed by recent molecular typing strategiesEpidemiology and risk factors for invasive candidiasisControl and manipulation of pathogens with an optical trap for live cell imaging of intercellular interactionsFlow Cytometry-Based Method To Detect Persisters in Candida albicans.Validation of the tetracycline regulatable gene expression system for the study of the pathogenesis of infectious diseaseThe conserved Candida albicans CA3427 gene product defines a new family of proteins exhibiting the generic periplasmic binding protein structural foldCandida albicans infection of Caenorhabditis elegans induces antifungal immune defensesReal-time PCR in clinical microbiology: applications for routine laboratory testing.Probing the Active Site ofCandida glabrataDihydrofolate Reductase with High Resolution Crystal Structures and the Synthesis of New InhibitorsCrystal Structures of Candida albicans Dihydrofolate Reductase Bound to Propargyl-Linked Antifolates Reveal the Flexibility of Active Site Loop Residues Critical for Ligand Potency and SelectivityDetermination of mRNA half-lives in Candida albicans using thiolutin as a transcription inhibitorComparison of echinocandin antifungalsDevelopment of a high-throughput Candida albicans biofilm chipA new tool to quantify receptor recruitment to cell contact sites during host-pathogen interactionNosocomial candidemia; risk factors and prognosis revisited; 11 years experience from a Norwegian secondary hospitalIdentification of New Antifungal Compounds Targeting Thioredoxin Reductase of Paracoccidioides GenusAntioxidant, Antimicrobial and Cytotoxic Properties as Well as the Phenolic Content of the Extract from Hancornia speciosa GomesActive and passive immunization with rHyr1p-N protects mice against hematogenously disseminated candidiasisActivity of crude extracts from Brazilian cerrado plants against clinically relevant Candida speciesEpidemiology of invasive candidiasis: a persistent public health problemMulticenter evaluation of Candida QuickFISH BC for identification of Candida species directly from blood culture bottles.Interaction of Candida albicans with adherent human peripheral blood mononuclear cells increases C. albicans biofilm formation and results in differential expression of pro- and anti-inflammatory cytokines.Fungemia in a Spanish hospital: the role of Candida parapsilosis over a 15-year period.Excess mortality, hospital stay, and cost due to candidemia: a case-control study using data from population-based candidemia surveillance.Characteristics and risk factors for 28-day mortality of hospital acquired fungemias in ICUs: data from the EUROBACT study
P2860
Q21194915-41F1E506-41E2-4E3D-A1A4-19D0C496E8F3Q21999063-DEA4586A-C6D1-4319-9979-4479F6180732Q22305429-3826D893-DBFF-4853-B497-1220E5BE14CDQ24195090-54A69EC0-5C4A-4973-B7D1-67F6638E74E9Q24235328-3B094655-CA86-4551-A148-D486F635CD32Q24243803-A542B92B-C09B-4DCE-A1CF-D166B3B600DBQ24303620-5CDC3743-7C23-43AC-A87B-0B99B91314EEQ24537282-8BE83E7F-24BF-42BE-96D1-2D02D3532940Q24563657-4220BAB7-4D5B-44FC-89B3-CDF24D6F572EQ24628877-02708842-F1A7-49B7-9D18-F8D194FA2C80Q26471135-B03D5C98-138E-432A-AAFF-818CF7597B81Q26752567-8DA56974-A316-4695-8959-057EDD11D912Q26828993-1A46465C-BA45-4179-B651-F5E4A625E7C9Q26830053-F09047B2-F51B-4CBC-88F0-FBEF1ACE9643Q27012454-672A15D9-FD69-4751-8397-E3D271FD9841Q27023720-1C703243-AD0E-4C23-8F08-F0CFAC87504CQ27024911-B01742DB-BAB4-424A-87C4-34BBFBD6F2D8Q27313251-D38DCC19-0BA3-4018-A80C-403E4DE2414BQ27324379-6F9F9FAF-8C65-449A-B4D6-9FC8937A3D65Q27338028-2CD44629-F2E7-4333-9810-171148951831Q27348287-86D4A12A-BA4A-463C-AF83-41715E54EBA8Q27349803-94FF7FAD-354D-4583-AD8B-D81C2C5A93C4Q27472851-92BD16FA-5334-410E-840A-42F549B81151Q27653450-379436A4-DB7A-4662-B2D1-B9031061F0C2Q27670663-4F55C96C-1373-408D-A4B1-D4236708AAF2Q28268148-3B3A9DBD-F374-4AEC-93AC-5969F9D516CFQ28273738-F3DBFE6A-6D35-4A02-8578-66B0127CAF2EQ28477874-398DBFC3-33EA-49A7-BF15-8CEA478D7DD2Q28539165-5BAE18A5-D093-404C-B4BF-5385A961095EQ28541447-21B97AC3-F7A2-4C26-96E5-5724EB7E4C44Q28550999-773D4B6B-B557-4172-A95B-EF6F6F6F90F3Q28554670-086323B7-E534-4FF3-BC16-0E3C0818A210Q28744094-B65703EB-ABAD-4B36-9481-B329D27D62D7Q28830609-F943D020-7C14-4556-BD0D-B51A3A5F1F36Q29616758-E53CE753-5FEC-44BD-A584-4DF74FFBFD8BQ30300387-48DFF36F-B159-4B62-A91B-96CBC3148A88Q30479433-B64F4403-F87A-489C-B6F8-A61055C1EDB2Q30808061-5C1126D4-72F7-4212-8DC2-A3FBD16EC460Q30994297-166F9500-F9ED-4FD9-BE9C-EF4618B30B04Q31054881-30736919-D5E9-4CD1-8B81-453D6F53DA07
P2860
Attributable mortality of nosocomial candidemia, revisited.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Attributable mortality of nosocomial candidemia, revisited.
@en
Attributable mortality of nosocomial candidemia, revisited.
@nl
type
label
Attributable mortality of nosocomial candidemia, revisited.
@en
Attributable mortality of nosocomial candidemia, revisited.
@nl
prefLabel
Attributable mortality of nosocomial candidemia, revisited.
@en
Attributable mortality of nosocomial candidemia, revisited.
@nl
P2093
P2860
P50
P356
P1476
Attributable mortality of nosocomial candidemia, revisited.
@en
P2093
Jeff Vande Berg
Jianfang Hu
Kathleen Lee
Michael Pfaller
Olafur Gudlaugsson
Shane Gillespie
P2860
P304
P356
10.1086/378745
P407
P577
2003-10-08T00:00:00Z